Unusual vasovagal-type autonomic dysfunction secondary to immune checkpoint inhibitor therapy

被引：0

作者：

Danley, Kelsey ^{[1
]}

Fidler, Mary Jo ^{[2
]}

Sadaf, Aliyah ^{[1
]}

Okwuosa, Tochukwu M. ^{[3
]}

机构：

[1] Rush Univ, Med Ctr, Internal Med, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Oncol, Chicago, IL USA

[3] Rush Univ, Med Ctr, Dept Internal Med, Div Cardiol, Chicago, IL USA

来源：

BMJ CASE REPORTS | 2023年 / 16卷 / 02期

关键词：

Cancer; see Oncology; Cancer intervention; Cardiovascular system; ADVERSE EVENTS;

D O I：

10.1136/bcr-2022-251034

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present the case of a patient with oral squamous cell carcinoma treated with the programmed death ligand inhibitor, pembrolizumab, an immune checkpoint inhibitor. She subsequently developed vasovagal-type autonomic dysfunction thought to be secondary to the pembrolizumab. The patient's vasovagal symptoms resolved with the initiation of oral glucocorticoids.

引用

页数：3

共 50 条

[21] Immune checkpoint inhibitor therapy for hepatocellular carcinoma
Ramai, Daryl
Shapiro, Alexandra
Facciorusso, Antonio
Bareggi, Claudia
Gambini, Donatella
Rijavec, Erika
Tomasello, Gianluca
Galassi, Barbara
Ghidini, Michele
ANNALS OF GASTROENTEROLOGY, 2022, 35 (06): : 568 - 576
[22] Advanced Research on Immune Checkpoint Inhibitor Therapy
Imai, Hisao
Kaira, Kyoichi
Kagamu, Hiroshi
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
[23] Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Gubbi, Sriram
Vijayvergia, Namrata
Yu, Jian Q.
Klubo-Gwiezdzinska, Joanna
Koch, Christian A.
HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 795 - 812
[24] Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
Lee, Juwon
Han, Youngjin
Wang, Wenyu
Jo, HyunA
Kim, Heeyeon
Kim, Soochi
Yang, Kyung-Min
Kim, Seong-Jin
Dhanasekaran, Danny N.
Song, Yong Sang
BIOMOLECULES, 2021, 11 (08)
[25] Neurotoxicities associated with immune checkpoint inhibitor therapy
Duong, Sophie L.
Barbiero, Frank J.
Nowak, Richard J.
Baehring, Joachim M.
JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (02) : 265 - 277
[26] Myocarditis induced by immune checkpoint inhibitor therapy
Baig, Muhammad Akbar
Brambl, Wells
Heuser, William
CLINICAL TOXICOLOGY, 2022, 60 : 118 - 119
[27] GASTROPARESIS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY
Rivera, Andres C. Urias
Machado, Antonio Pizuorno
Shatila, Malek
Wang, Yinghong
Shafi, Mehnaz
GASTROENTEROLOGY, 2024, 166 (05) : S1078 - S1079
[28] Neuromuscular complications of immune checkpoint inhibitor therapy
Kolb, Noah A.
Trevino, Christopher R.
Waheed, Waqar
Sobhani, Fatemeh
Landry, Kara K.
Thomas, Alissa A.
Hehir, Mike
MUSCLE & NERVE, 2018, 58 (01) : 10 - 22
[29] Immune Checkpoint Inhibitor Therapy Associated Hypophysitis
Mahzari, Moeber
Liu, Dora
Arnaout, Amel
Lochnan, Heather
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2015, 8 : 21 - 28
[30] Neurotoxicities associated with immune checkpoint inhibitor therapy
Sophie L. Duong
Frank J. Barbiero
Richard J. Nowak
Joachim M. Baehring
Journal of Neuro-Oncology, 2021, 152 : 265 - 277

← 1 2 3 4 5 →